Slides
Page 2
Today‘s Agenda 09:30 a.m. 10:45 a.m. 12:00 p.m. 11:15 a.m. Leading Transformation Marc Werner Transforming Our Pharmacies Coffee Break & Booths Consumer Healthcare Market Transforming Operational Excellence Lunch & Booths Daniele Madonna, Virginie Pache, Stephan Mignot Thomas Szuran Andreas Koch 01:30 p.m. Galenica Diagnostics Financial Outlook Alain Cahen Julian Fiessinger 02:15 p.m. Guided Stapferhaus Mini-Tour & Apéro
Page 3
Visit Our Market Booths on the 1st Floor Future Pharmacy Experience Visit the mock-up of our pilot pharmacy Consulation plus Services Diabetes Check Blood Pressure Check Ear Check Prescription Manager and E-Prescription Register for the digital prescription tool and get to know the E-Prescription Cooperation with KPT Learn more about the new insurance model labor team & Diagnostics Get to know labor team
Page 4
Leading the Transformation towards an Integrated Healthcare System Marc Werner, CEO
Page 5
« Transformation starts with culture, not technology.»
Page 6
New forms of collaboration New store concepts New roles
Page 7
Vision Strategy Added value in the network We generate value for customers and partners Omnichannel Health Services & Products Strategy Shaping the future We are shaping the healthcare of tomorrow Digital Health Connecting Healthcare Values Sustainably successful We work efficiently and effectively Efficiency Sustainability (ESG) Pioneers in transition We rethink and move forward together Transformation Employer of choice Galenica Story
Page 8
Transformation of Wholesale & Logistics is on track
Page 9
Strengthening our network with labor team Extension of value chain Innovation in pharmacies Wide product range for physicians Large potential customer base
Page 10
Integrating the Swiss healthcare system Bringing actors together Software as a connector Integrating along customer journeys
Page 11
Clear strategic priorities Continued development of the pharmacy business and Products & Brands Organic growth and efficiency gains in Wholesale & Logistics Establishing the diagnostics business, expanding Home Care
Page 12
Transforming Our Pharmacies to Strengthen Our Healthcare System Daniele Madonna, Head Pharmacies Category Management & Health Services Virginie Pache, Head Pharmacies Sales Stephan Mignot, Head Pharmacies Marketing
Page 13
1‘830 Key role of pharmacies in our healthcare system Switzerland Galenica No. of pharmacies 381
Page 14
Transforming our pharmacies Positioning our pharmacies as the first point of contact for health questions Attracting, retaining and developing top talent Investments in a comprehensive omni-channel strategy Daniele Madonna Virginie Pache Stephan Mignot 1 2 3
Page 15
More responsibilities for pharmacies starting 2027 Cost coverage for vaccination in national vaccine-planVaccinations Patient monitoring, adapting therapy, medication analyses - in consultation with physicians Treatment adherence & optimisation Examinations and preventive measures in national and cantonal programmsPrevention
Page 16
“Consultation plus” as a standard for health services in pharmacies Vaccinations: in nearly all network pharmacies Top-seller consultations: erectile dysfunction, gastrointestinal, skin and urinary infections H1/23 H2/23 H1/24 H2/24 H1/25 173’694 216’984 147’895 194’923 119’280 Fee-based services
Page 17
Cooperations with health insurances for coverage of costs for our services 170’000 insured people Further cooperation partners Booth upstairs
Page 18
“Consultation plus” as a customer retention tool Average basket cross-selling, customer satisfaction & retention Ambition twice as many consultations within 3 years CHF 80 Potential Products Consultation
Page 19
Recruitment of specialists has improved More responsibilities New role-based organisation in pharmacies Career-paths within the network
Page 20
Investments in education and training of all Swiss pharmacy student residencies ¼ pharmacy co-management teams 30 FPH certificates for pharmacists financed 428
Page 21
Efficient personnel planning thanks to internal staffing pool employees in our internal staffing pool 277 18 184 75 assistants perfumery pharmacists 08/2025
Page 22
of customers check online before visiting stores 80%
Page 23
OTC liberalisation is an opportunity – omni-channel as our strategy Redcare as a pure online player Developing online shops & digital customer journey Investing into future pharmacy experience
Page 24
Investing into future pharmacy experience More interaction with clients Private cosultation booths Inclusion of digital tools Booth upstairs
Page 25
Developing online shops & digital customer journey click & collect orders this year +50% Prescription Manager users 30k Booth upstairs
Page 26
Pharmacy as a modern health center Pharmacies as first point of contact Investments into our employees Omni-channel experience Client satisfaction and retention Securing strong worforce Gaining market shares
Page 27
Consumer Healthcare: A Market with Growth Potential Thomas Szuran, Chief Products & Home Care
Page 28
of the Swiss population plan to take greater care of their own healthcare 46% GFS-Bern, BAG rate their health literacy as high to very high 75% of the population feel «very healthy» 11%
Page 29
Self optimisation Prevention Informed customers Demographic change Market with growth opportunities Price sensitivity Global supply chains Omni-channel
Page 30
Proven M&A track record as key to market share growth Acquisition Padma® Distribution Allergosan® Acquisition Hedoga Group Distri- bution Bucco- Tantum® Distribution ThermaCare ® Distribution Uriage® Acquisition Merfen® and Vita-Merfen® Distribution Mustela® Distribution Lierac and Phyto Launch Distribution Vicks and Metamucil Distribution Excilor Acquisition Dr. Wild Distribution Oenobiol Distribution Boiron® Acquisition Spagyros® Market share Distribution Cooper Consumer Health® 0.0 0.1 2017 2018 2019 2020 2021 2022 2023 2024 OTC Beauty Complementary Medicine 10.0% 8.0% 6.0% 4.0%
Page 31
Bridging stock effects: Perskindol & Triomer Inventory build-up Inventory reduction 0 1 2 3 4 5 6 7 8 9 2024 2025 2026 2027 in million CHF
Page 32
Strengthening our market-leading position Product development Line extensions Omni-channel marketing Health content Long-term brand building Trust & recognisability
Page 33
Transforming Operational Excellence in Wholesale & Logistics Andreas Koch, Chief Wholesale & Logistics
Page 34
packages of pharmaceutical products pass through our logistics facilities each year 100‘000‘000
Page 35
Increasing medication use and number of generic medications 08/2025 200 million Market Shares Pharmaceutical Market Switzerland 7.8 4.9 31.6 17.8 35.0 Rx Pharmacies Rx PhysiciansOTC Pharmacies OTC Physicians OTC Drogerie (3.0) Hospitals Packages of pharmaceutical products per year in Switzerland
Page 36
Building up safety stocks to improve supply products not available 700 generic drugs with safety stocks 350 higher inventory for Safety Stock products 5x
Page 37
Investing in automation and digitization in Wholesale & Logistics
Page 38
Alloga Burgdorf 20% increase in efficiency Implemented Galexis Lausanne-Ecublens Roll-out in March 2025 Implemented Galexis Niederbipp Completion mid 2026
Page 39
Implemented Galexis Niederbipp Completion mid 2026 Galexis Lausanne-Ecublens Roll-out in March 2025 Implemented
Page 40
Efficiency gains from hardware updates realised Focus on finalising implementation of SAP and switch to new Enterprise Warehouse Management Galexis Niederbipp Completion mid 2026 ImplementedImplemented
Page 41
Artificial intelligence improves processes Forecasting Capacity planning Customer support Article allocation
Page 42
Focused on securing supply in Switzerland Efficiency in processes thanks to automation Scalability of our operations due to digitisation Reliability of services for our clients
Page 43
labor team: Integrating Healthcare Through Diagnostics Alain Cahen, CEO labor team
Page 44
of all diagnoses are based on lab analyses 70%
Page 45
Fourth largest lab in Switzerland Established player with deep market knowledge Investments in innovation, infrastructure & digitalisation Strong foundation for growth with Galenica
Page 46
Dynamic market Increasing test volumes Opportunity to gain market shares due to additional tests 1 Outsourcing of practice & hospital labs Rising diagnostics volume due to demographics, prevention and health conditions 2 Market consolidation Further tariff cuts likely to boost growth of efficient large labs 3 Regulatory environment Scalability and automation will provide advantage 4 Market Trends & Opportunities 7% 36% 57% Source: BAG Monitoring Bericht (2019); LEK (2025) 1.4 0.9 0.8 Physician Labs Private Labs Hospital Labs Market Segments in billion CHF Viollier Unilabs Sonic Suisse Small & medium sized labs Private Labs in billion CHF 0.1 0.5 0.8
Page 47
7.000.000 tests each year 2000 types of tests 99.5% tests in-house Physician-led Lab medicine and pathology combined
Page 48
Fast results Automation Innovation
Page 49
Fast results 60 logistics partners 30 minutes – 5 hours delivery time to Goldach Logistics network & central lab ensure fast results Digital order, blood sampling and pickup Automation Innovation
Page 50
Fast results Automation Innovation Movie
Page 51
Fast results Automation Innovation Efficiency through automation and scalability 3 automations Clinical chemistry Immunology Hematology Core Lab Anatomical pathology Microbiology Coming soon
Page 52
Fast results Automation Innovation 15 new tests in 3 years
Page 53
Fast results Automation Innovation 80% electronic orders, results transmitted digitally to patient’s dossier 30 internal IT specialists Focus on what we do best Certified green & sustainable Lab
Page 54
Clear focus for our future Organic growth Thanks to outstanding service and innovative offering Opportunities Inorganic growth by utilising targeted market opportunities Strong network Being part of Galenica as the next step in our successful journey
Page 55
Financial and Market Outlook Julian Fiessinger, CFO
Page 56
Favourable market environment with steady growth rates Pharmaceutical market Steady volume, increasing of prices due to innovation Consumer Healthcare Market Flat growth Diagnostics Market Increasing testing volume, innovation, price cuts reimbursement
Page 57
Well positioned for the future 3 2 1Cost reduction Tariffing Digitisation
Page 58
Well positioned for the future 1 2 3 1/3 of all medication prices reviewed No repeal of the territorial principle New remunderation rates for MiGel TransAL2 and TarDoc in lab business Cost reduction Tariffing Digitisation
Page 59
Well positioned for the future 1 2 3 Approval of LOA V by Federal Council Cost reduction Tariffing Digitisation
Page 60
Well positioned for the future 1 2 3 OTC liberalisation in 2029-2030 at the earliest We contribute to DigiSanté and the adoption of e-prescription and eMediplan New revenue segmentation Cost reduction Digitisation Tariffing
Page 61
New revenue segmentation Products & Care Previously Logistics & IT Wholesale Logistics & IT Services Products & Care Retail (B2C) Local Pharmacies Pharmacies at Home Professionals (B2B) Products & Brands Services for Professionals New Products & Care Pharmacies Omni-Channel Products & Brands Services & Production Diagnostics Logistics & IT Wholesale Logistics & IT ServicesInternal Services Pharma Internal Services Homecare
Page 62
Guidance 2025 1. Excluding effects of IAS 19 and IFRS 16, see chapter “Alternative performance measures” of the Half year report 2025 and the adjustment for Labor Team acquisition related PPA effects. Net Sales Dividend EBIT1 10-12 % at least at previous year’s level4-6 % Previously 3-5 % Previously 7-9 % adjusted due to one-off effect of CHF 5.4 million and acquisition of Labor Team raised due to acquisition of Labor Team
Page 63
Mid-term 2027 guidance on track Net Sales Growth ROS EBIT Capex and Net Debt Dividends 3-5% Products & Care: >9.5% Logistics & IT: up to 2% > CHF 250 million Stable Capex Net Debt +/- 2 x EBITDA Stable growth in line with results
Page 64
Today’s key take-aways Leading the Transformation Towards an Integrated Swiss Healthcare System A Strong Foundation for Transformation: Defensive Resilience, History of Growth, Strategic Focus Transforming Our Pharmacies Potential in the Consumer Healthcare Market Transorming Operational Excellence Integrating Healthcare Through Diagnostics Investments into omni- channel strategy and securing our workforce Continued portfolio expansion, focus on sales and marketing channels Focus on efficiency, scalability and reliability As a part of Galenica building on innovation and utilizing opportunities
Page 65
Thank you!
Page 66
Outro Mood Images TBD